Expression and characterization of a recombinant soluble form of bovine tumor necrosis factor receptor type I

Veterinary Immunology and Immunopathology

Volumn 77, Issue 3-4, 2000, Pages 233-241

  Mwangi, Simon M ^a   Stabel, Judy ^b   Lee, Eun Kyung ^a   Kehrli Jr , Marcus E ^b   Taylor, Michael J ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

Bovine; Expression; Pichia; Receptor; Tumor necrosis factor alpha

Indexed keywords

ALCOHOL OXIDASE; COMPLEMENTARY DNA; METHANOL; RECOMBINANT TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CATTLE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXICITY; GENE CONSTRUCT; GENE INDUCTION; NONHUMAN; PICHIA PASTORIS; PROMOTER REGION; PROTEIN DOMAIN;

ANIMALS; ANTIGENS, CD; CATTLE; PICHIA; POLYMERASE CHAIN REACTION; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034731570     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(00)00244-0     Document Type: Article

References (26)

1. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock
2. Incidence of clinical mastitis in dairy herds grouped in three categories by bulk milk somatic cell counts
3. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences
4. Expression of TNF-alpha by human plasma cells in chronic inflammation
5. Coliform mastitis
6. Long-term protection against the effects of tumour necrosis factor by controlled delivery of the soluble p55 TNF receptor
7. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients
8. Inhibition of TNF by a TNF receptor immunoadhesin. Comparison to an anti-TNF monoclonal antibody
9. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors
10. Determination of tumor necrosis factor binding protein disulfide structure: Deviation of the fourth domain structure from the TNFR/NGFR family cysteine-rich region signature
11. Cloning and sequencing of cDNA encoding bovine tumor necrosis factor (TNF)-receptor I
12. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor
13. Identification of cysteine-rich domains of the type 1 tumor necrosis factor receptor involved in ligand binding
14. Elevated levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) activities in the sera and milk of cows with naturally occurring coliform mastitis
15. Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor
16. Tumor necrosis factor
17. Cytokine production during endotoxin-induced mastitis in lactating dairy cows
18. Bacterial growth, inflammatory cytokine production, and neutrophil recruitment during coliform mastitis in periparturient versus midlactation cows
19. Detection and neutralization of bovine tumor necrosis factor by a monoclonal antibody
20. Environmental mastitis
21. Effect of interferon-gamma on the production of tumor necrosis factor during acute Escherichia coli mastitis
22. High-level expression, purification, and characterization of recombinant human tumor necrosis factor synthesized in the methylotrophic yeast Pichia pastoris
23. Tumor necrosis factor: A pleiotropic cytokine and therapeutic target
24. High-level secretion of glycosylated invertase in the methylotrophic yeast, Pichia pastoris
25. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo
26. Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55kDa TNF receptor (CD120a)-Ig fusion protein, Ro 45-2081